Location History:
- Dunwoody, GA (US) (1989 - 1997)
- Decatur, GA (US) (2002)
Company Filing History:
Years Active: 1989-2002
Title: The Innovative Contributions of Inventor Alexander Duncan
Introduction
Alexander Duncan, an accomplished inventor based in Dunwoody, Georgia, is the holder of 16 patents that showcase his innovative spirit and dedication to advancing medical science. His work spans crucial medical applications, particularly in the fields of blood coagulation and tumor treatment, demonstrating his commitment to improving health outcomes.
Latest Patents
Two of Alexander Duncan's latest patents highlight his groundbreaking research and development efforts. The first patent describes a method for measuring antithrombin activity, which is essential for understanding antifibrinolytic therapy. This one-stage method involves mixing a diluted sample with AT-deficient plasma and other critical components, followed by measuring coagulation time to assess antithrombin levels.
The second patent presented by Duncan focuses on a method for treating tumors. This innovative approach entails injecting a solution containing specific surface-active copolymers along with chemotherapeutic agents directly into the tumor-affected area. This method provides a novel means of cancer treatment, allowing for the simultaneous or sequential introduction of therapeutic agents.
Career Highlights
Duncan has had a notable career, working for prominent institutions such as Emory University and Lifesource Advanced Blood Bank Systems, Inc. During his tenure, Duncan has devoted his efforts to research that has significant implications for medical treatments and diagnostics. His diverse experience has allowed him to contribute valuable innovations in biotechnology and medical device development.
Collaborations
Throughout his career, Alexander Duncan has collaborated with esteemed colleagues, including Robert L. Hunter and Frank H. Harms. These partnerships have fostered an environment of shared knowledge and creativity, allowing for the enhancement of Duncan's inventions and contributing to the success of their joint projects.
Conclusion
In summary, Alexander Duncan has made significant strides in innovation through his 16 patents, marking him as a prominent figure in the area of medical research. His contributions, particularly in antithrombin activity measurement and tumor treatment methods, reflect his dedication to advancing healthcare technologies. As he continues to work alongside distinguished colleagues, it is clear that Duncan's innovations will have a lasting impact on the medical community.